ACAD
30.46
-0.59
-1.90%
AEMD
0.25
0.00
-1.19%
APRI
1.39
-0.04
-2.80%
ARNA
4.32
-0.2
-4.32%
ATEC
1.29
-0.02
-1.53%
CFN
59.33
-0.28
-0.46%
CNAT
5.82
-0.14
-2.35%
CRXM
0.21
0.00
-1.38%
CYTX
0.48
+0.01
+1.89%
DXCM
59.81
-1.19
-1.95%
GNMK
12.89
-0.42
-3.16%
HALO
14.29
-0.3
-2.06%
ILMN
195.68
-4.32
-2.16%
INNV
0.22
+0.01
+4.19%
INO
8.33
-0.17
-2.00%
ISCO
0.06
0.00
0.00%
ISIS
68.56
-1.3
-1.86%
LGND
56.43
-0.6
-1.05%
LPTN
2.76
-0.09
-3.16%
MBVX
1.04
-0.01
-0.95%
MEIP
3.98
+0.12
+3.11%
MNOV
3.79
+0.02
+0.53%
MRTX
20.67
-0.62
-2.91%
MSTX
0.45
+0.01
+3.37%
NBIX
33.71
-0.64
-1.86%
NUVA
46.31
-0.99
-2.09%
ONCS
0.36
-0.01
-2.74%
ONVO
6.41
-0.28
-4.19%
OREX
5.26
-0.1
-1.78%
OTIC
29.25
-2.32
-7.35%
QDEL
23.53
-0.94
-3.84%
RCPT
110.06
-2.65
-2.35%
RGLS
19.15
+0.57
+3.04%
RMD
62.52
-0.51
-0.81%
SCIE
0.01
0.00
-2.65%
SPHS
0.48
+0.01
+1.34%
SRNE
10.1
-0.68
-6.31%
TROV
6.48
+0.65
+11.17%
VICL
1.03
-0.01
-0.96%
VOLC
17.96
0.00
0.00%
ZGNX
1.36
-0.01
-0.74%
Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Sequenom Inc. Announces Participation At The 33rd Annual Healthcare Conference

January 5, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 6, 2015 /PRNewswire/ –Sequenom, Inc. (NASDAQ: SQNM), a leading molecular diagnostics company, today announced the Company’s participation at the 2015 J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, in San Francisco, CA on

Isis Pharmaceuticals, Inc. Appoints As President And Chief Executive Officer Of

January 5, 2015 – 5:00 pm | Edit Post

CARLSBAD, Calif. and CAMBRIDGE, Mass., Jan. 6, 2015 /PRNewswire/ — Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the appointment of Paula Soteropoulos as president and chief executive officer (CEO) of Akcea Therapeutics, the Isis-owned…

Fate Therapeutics To Present At

January 5, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 6, 2015 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life-threatening diseases, today announced that Christian Weyer, M.D., M.A.S., President and Chief…

Former President Of Biotechnology Industry Organization (BIO) Joins TrovaGene, Inc.’s Board Of Directors

January 5, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 6, 2015 /PRNewswire/ –Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that Carl Feldbaum, president emeritus of the Biotechnology Industry Organization (BIO), the world’s largest biotechnology trade association, has…

Arena Pharmaceuticals, Inc. To Present At The 33rd Annual Healthcare Conference

January 5, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 6, 2015 /PRNewswire/ — Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015, at

Otonomy, Inc. To Present At The Healthcare Conference

January 5, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 6, 2015 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that David A. Weber, Ph.D., president…

Isis Pharmaceuticals, Inc. Appoints As Chief Business Officer

January 5, 2015 – 5:00 pm | Edit Post

CARLSBAD, Calif., Jan. 5, 2015 /PRNewswire/ –Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that Sarah Boyce has joined the company as chief business officer. In this newly created position, Ms. Boyce will provide strategic leadership from a commercial background and…

Apricus Biosciences To Present At

January 5, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 6, 2015 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced Richard Pascoe, Chief Executive Officer, will present at the Biotech Showcase 2015 Conference on Monday, January…

Conkwest, Sorrento Therapeutics, Inc. And <b>NantWorks</b> Announce Presentation At The 33rd Annual <b>J. P. Morgan</b> Healthcare Conference By <b>Dr. Patrick Soon-Shiong</b>

January 5, 2015 – 5:00 pm | Edit Post

SAN DIEGO, Jan. 6, 2015 /PRNewswire/ — Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and Conkwest, Inc., an immuno-oncology company developing proprietary Neukoplast, a Natural Killer (NK) cell-line based therapy, announced today that Dr.

NuVasive, Inc. To Participate In Investor Event In January 2015

January 5, 2015 – 5:00 pm | Edit Post

SAN DIEGO, CA–(Marketwired – January 05, 2015) – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor event in January 2015:…